1. Home
  2. Analysis
  3. Atrovent
  4. Abreva

Atrovent and Abreva drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Atrovent and Abreva. Common interactions include hypokinesia among females.

The phase IV clinical study analyzes what interactions people who take Atrovent and Abreva have. It is created by eHealthMe based on reports of 10 people who take Atrovent and Abreva from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Mar, 18, 2023

10 people who take Atrovent and Abreva together, and have interactions are studied.

What is Atrovent?

Atrovent has active ingredients of ipratropium bromide. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 29,808 Atrovent users for its effectiveness, alternative drugs and more.

What is Abreva?

Abreva has active ingredients of docosanol. It is often used in herpes labialis (oral herpes simplex). eHealthMe is studying from 16,320 Abreva users for its effectiveness, alternative drugs and more.

Number of Atrovent and Abreva reports submitted per year:

Atrovent and Abreva drug interactions.

Common Atrovent and Abreva drug interactions by gender *:

female:

  1. Hypokinesia
  2. Drug withdrawal syndrome
  3. Hypersensitivity
  4. Immune system disorder
  5. Increased tendency to bruise
  6. Joint lock
  7. Joint stiffness
  8. Joint swelling
  9. Nocturia
  10. Rash

male:

n/a

Common Atrovent and Abreva drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Fibromyalgia
  2. Hypokinesia
  3. Pain
  4. Drug withdrawal syndrome
  5. Impaired work ability

50-59:

n/a

60+:

  1. Arthralgia
  2. Asthenia
  3. Joint stiffness
  4. Joint swelling
  5. Nocturia
  6. Rash
  7. Sinus congestion
  8. Sjogren's syndrome
  9. Synovial cyst
  10. Viral infection

Common conditions people have *:

  1. Wheezing (a high-pitched whistling sound made while you breath): 7 people, 70.00%
  2. Stress And Anxiety: 7 people, 70.00%
  3. Muscle Aches (muscle pain): 7 people, 70.00%
  4. Fibromyalgia (a long-term condition which causes pain all over the body): 7 people, 70.00%
  5. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 30.00%
  6. Insomnia (sleeplessness): 1 person, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Atrovent and Abreva?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Alternative drugs to, pros and cons of the 2 drugs:

Browse all drug interactions of Atrovent and Abreva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Atrovent side effects:

Browse all side effects of Atrovent:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Abreva side effects:

Browse all side effects of Abreva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Atrovent interactions:

Browse all interactions between Atrovent and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on ipratropium bromide and docosanol (the active ingredients of Atrovent and Abreva, respectively), and Atrovent and Abreva (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Atrovent and Abreva.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.